ARG58292

anti-CD263 / TRAIL R3 antibody [1E12]

anti-CD263 / TRAIL R3 antibody [1E12] for Western blot and Human

Overview

Product Description Mouse Monoclonal antibody [1E12] recognizes CD263 / TRAIL R3
Tested Reactivity Hu
Tested Application WB
Host Mouse
Clonality Monoclonal
Clone 1E12
Isotype IgG1, kappa
Target Name CD263 / TRAIL R3
Antigen Species Human
Immunogen Recombinant protein corresponding to aa. 26-236 of Human CD263 / TRAIL-R3.
Conjugation Un-conjugated
Alternate Names Lymphocyte inhibitor of TRAIL; Antagonist decoy receptor for TRAIL/Apo-2L; TNF-related apoptosis-inducing ligand receptor 3; DCR1; TRID; CD antigen CD263; Tumor necrosis factor receptor superfamily member 10C; CD263; Decoy TRAIL receptor without death domain; LIT; Decoy receptor 1; DcR1; DCR1-TNFR; TRAIL-R3; TRAIL receptor 3; TRAILR3; TRAIL receptor without an intracellular domain

Application Instructions

Application Suggestion
Tested Application Dilution
WB1:1000
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Properties

Form Liquid
Purification Purification with Protein A.
Buffer PBS (pH 7.4), 0.02% Sodium azide and 10% Glycerol.
Preservative 0.02% Sodium azide
Stabilizer 10% Glycerol
Concentration 1 mg/ml
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 8794 Human TNFRSF10C

Swiss-port # O14798 Human Tumor necrosis factor receptor superfamily member 10C

Gene Symbol TNFRSF10C
Gene Full Name tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
Background The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain. This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis. This gene was found to be a p53-regulated DNA damage-inducible gene. The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL. [provided by RefSeq, Jul 2008]
Function Receptor for the cytotoxic ligand TRAIL. Lacks a cytoplasmic death domain and hence is not capable of inducing apoptosis. May protect cells against TRAIL mediated apoptosis by competing with TRAIL-R1 and R2 for binding to the ligand. [UniProt]
Calculated MW 27 kDa
PTM N-glycosylated and O-glycosylated. [UniProt]

Images (1) Click the Picture to Zoom In

  • ARG58292 anti-CD263 / TRAIL R3 antibody [1E12] WB image

    Western blot: 40 µg of Human liver lysate stained with ARG58292 anti-CD263 / TRAIL R3 antibody [1E12] at 1:1000 dilution.